TAK | ZTS | HLN | TEVA | NBIX | VTRS | |
---|---|---|---|---|---|---|
Company Name | Takeda Pharmaceutical Company Limited | Zoetis Inc. | Haleon plc | Teva Pharmaceutical Industries Limited | Neurocrine Biosciences, Inc. | Viatris Inc. |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Market Cap | $43.45B | $82.06B | $42.15B | $19.37B | $14.77B | $14.38B |
Employees | 49.28K | 14.10K | 25.41K | 35.00K | 1.45K | 33.00K |
CEO | Mr. Christophe Weber | Ms. Kristin C. Peck | Mr. Brian James McNamara | Mr. Richard D. Francis | Dr. Kevin C. Gorman Ph.D. | Mr. Scott Andrew Smith |